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ABSTRACT: We developed a simple 3D printed car-
tridge for mass spectrometry (MS) targeted detection of 
plasma proteins, including post-translational modifica-
tions (PTMS).  The cartridge uses an integrated antibody 
enrichment column to preconcentration the protein target 
as well as a novel built-in substrate to ionize the protein 
targets for MS detection. We show several examples of 
using this cartridge to perform rapid detection of clini-
cally significant proteoforms from plasma samples. 
Protein molecules and targets are measured in clinical 
diagnostic laboratories as tumor markers, acute or chron-
ic disease markers, risk or prognostic markers, and hor-
mones.  Immunoassays have been successfully used for 
decades to detect protein analytes in clinical laborato-
ries, but there remain limitations of this approach.  
Monoclonal antibodies are expensive to develop and 
manufacture.  Moreover, there are well recognized ana-
lytical limitations;  for example, most immunoassays do 
not distinguish between the various proteoforms and 
variants of a protein present in clinical samples.1 
Targeted enrichment of proteins followed by MS de-
tection is a widely used approach to detect different pro-
teoforms. Enrichment is generally performed using anti-
bodies because of their ability to selectively enrich target 
proteins from protein rich matrices such as plasma. Mass 
spectrometric immunoassay (MSIA) uses antibody coat-
ed beads packed into a pipette tip2 followed by detection 
of intact proteins by MALDI-MS. Another approach is 
antibody modification of the MALDI target.3-5 In 
SISCAPA (stable isotope standards and capture by anti-
peptide antibodies) and immuno-MALDI, enrichment is 
performed at the peptide level after digestion.6-7 Peptide 
level enrichment gives better quantitation and improved 
sensitivity. However, limited sequence coverage compli-
cates detection of PTMs and sequence variants. 
Development of a simple MS assay capable of resolv-
ing proteoforms would have a significant impact on pro-
tein detection, including clinical testing. We previously 
reported simple, single-use MS cartridges for the analy-
sis of drugs which integrated sample preparation, sample 
storage as a dried spot, and analyte ionization via paper 
spray, in which paper is used as an inexpensive solid 
support for extraction, fluid transport, and electrospray 
ionization.8-9 Here, we describe the development of a 
mass spectrometry cartridge designed for targeted detec-
tion of proteins from complex biofluids such as plasma. 
Selective enrichment of protein targets is performed on-
cartridge passively by capillary action and gravity with 
no pumping.  Detection of the intact protein targets then 
proceeds via ionization of the protein target using a 
built-in spray substrate consisting of carbon-nanotube 
(CNT) coated porous polyethylene. The distinguishing 
feature of this approach is its simplicity and low cost, in 
effect a combination of inexpensive lateral flow assays 
with mass spectrometry. Three applications of this car-
tridge are described for clinically significant problems: 
1) identification of T45S variant of apolipoprotein c1, a
polymorphism associated with body mass index and
obesity, 2) relative quantitation of hemoglobin (Hb)
A1C, a marker of diabetes, and 3) identification of se-
quence variants of transthyretin, which are markers of
transthyretin-related hereditary amyloidosis.
A 3D printed cartridge (Figure 1) was developed to 
perform the entire analyte preconcentration and ioniza-
tion process. An absorbent waste pad in the base of the 
cartridge draws the sample through the antibody column, 
which consisted of a plastic tube packed with glass fiber 
membranes coated with latex bead-antibodies conju-
gates. All parts were assembled together, and the column 
holder was slid along the groove between lid and base to 
switch the position of the antibody column from above 
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the waste pad, where the sample addition and washing 
steps occurred, to above the spray substrate where ioni-
zation by substrate supported electrospray ionization 
occurred.  MS detection was performed on a quadru-
pole-orbitrap mass spectrometer in full scan mode. 
 
 
Figure 1. Schematic diagram and photograph of the anti-
body cartridge. The inserted photograph shows the assem-
bled cartridge in the sample loading/wash. The antibody 
column extracted target protein from the plasma and a 
CNT-coated porous polyethylene spray tip was used for 
substrate supported electrospray.  
A number of reports describe the use of paper spray 
MS for the detection of drugs and other small molecules 
from blood.10-11 The detection efficiency of proteins by 
paper spray is relatively poor, however.  A paper spray 
based immunoassay was reported in which a charged 
probe released from the bound antibody was detected by 
MS.12 Although this approach has better sensitivity be-
cause a small molecule is used for detection, the selec-
tivity is ultimately limited by the antibody. Detection of 
the probe cannot give any information on the antigen 
such as PTMs. Improved protein ionization has been 
reported using paper coated with CNT13 as well as size 
exclusion membranes.14 Carbon nanotube coated paper 
has also been utilized for low voltage paper spray.15 We 
investigated CNT treated paper and as well as a novel 
substrate, CNT treated porous polyethylene (PE). Photo-
graphs and scanning electron microscope images of the 
spray substrates are shown in Figure S1. Detection limits 
of the three proteins were improved by coating or dis-
persing chromatography paper with single-walled CNT 
(Table S1). The CNT-coated PE even further improved 
protein detection; CNT-coated PE detection limits were 
between 10 and 100 times lower compared to the best 
obtained using CNT treated paper. Detection limits of 
the protein standards were improved by a factor of 50-
1000 compared to typical paper spray. Mass spectra ob-
tained using paper and CNT-coated PE for three stand-
ard protein solutions are shown in Figure 2. 
The Taylor cone generated from the CNT-coated PE 
tip was significantly smaller compared to paper (Figure 
3). The size of the Taylor cone correlates with droplet 
size, and smaller electrospray droplets correlate with 
better ionization efficiency.16 The improved protein de-
tection from the CNT-coated PE substrate therefore may 
arise from balancing the surface energy of the substrate 
with that of the solvent to generate smaller droplets and 
more efficient ionization.  The substrate must be suffi-
ciently wettable to allow wicking by a polar solvent, 
necessary to drive fluid and analyte transport, but not so 
wettable that the Taylor cone is large. The CNT-PE sub-
strate was also found to retain less protein than paper, 
but the difference was small compared to the improve-
ment in detection limits (supplementary material). 
 
Figure 2. Full MS spectra obtained by ionizing 10 μg/mL 
cytochrome c using paper spray (a) and the CNT-coated PE 
substrate (b). Spectra for two other proteins are in supple-
mentary figure S2. 
To achieve selective and sensitive detection of target 
proteins from biofluids, we utilized an antibody column 
integrated into the cartridge. In this method, protein pre-
concentration was performed using a membrane contain-
ing latex bead-antibody conjugates. The plasma sample 
was added to the antibody column where it flowed 
through by a combination of capillary action and gravity. 
Excess sample was absorbed into a built-in waste pad in 
the bottom cartridge, while the target protein was re-
tained on the latex bead conjugates. A washing step was 
performed by subsequently adding water to the precon-
centration column, where it wicked into the waste pad. 
The protein analyte was then detected by sliding the an-
tibody column to the elution position above the spray 
substrate and adding 1:1 methanol:water with 2% acetic 
acid, which acted as both the extraction solution and the 
spray solvent.  Over 90% of captured protein was eluted 
in the case of cytochrome C (supplemental material). 
 
Figure 3. Taylor cone generated from CNT-PE and paper. 
The diameter of the Taylor cone generated from the sharp 
point of CNT-PE was much smaller compared with paper. 
CNT-coated paper is pictured in supplementary figure S3. 
We used polyclonal antibodies as opposed to mono-
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clonal antibodies. While monoclonal antibodies are gen-
erally preferred in immunoassays because of their higher 
selectivity, polyclonal antibodies have a number of ad-
vantages for this application. Polyclonal antibodies have 
higher affinity compared to monoclonal antibodies, they 
bind to multiple different epitopes which minimizes the 
risk that a particular proteoform or variant will not bind, 
and they are cheaper than monoclonal antibodies. The 
lower selectivity of polyclonal antibodies is not a factor 
in this application because of the use of MS detection. 
This approach does necessitate that antibodies against 
the target protein be available. Antibodies are also the 
most expensive component of the cartridge.  However, 
use of antibodies in this cartridge are still significantly 
cheaper with faster development times than traditional 
immunoassays.  Because MS detection is used, high se-
lectivity monoclonal antibodies are not required, which 
decreases the cost and time associated with antibody 
generation. 
 
Figure 4. The MS protein detection cartridge analysis of 
human plasma apolipoprotein c1 (ApoC1). (a) full MS 
spectrum obtained from the pooled human plasma sample 
showing the ApoC1 full-length, truncated, and truncated 
T45S variant. Narrower MS scan range shows the truncated 
ApoC1 +6 ions obtained from (b) pooled human plasma 
and (c) individual donated plasma.  
We investigated three clinically significant applica-
tions of the MS protein detection cartridge. Apolipopro-
tein C1 (ApoC1) T45S variant is a naturally occurring 
amino acid polymorphism that has been associated with 
elevated body mass index and diabetes.17 As shown in 
Figure 4a, three ApoC1 species were identified in the 
MS spectrum obtained from a pooled human plasma 
sample, including full-length ApoC1 (6.6 kDa), truncat-
ed ApoC1(minus amino-terminal Thr-Pro, 6.4 kDa), and 
truncated T45S variant (∆m= -14.03 Da). Detection of 
the T45S variant in the pooled plasma sample indicated 
that some of plasma came from individuals with the 
ApoC1 S45 allele (figure 4b). The protein cartridge was 
also used to analyze plasma from a single donor; the 
mass spectrum indicates that the individual donor did 
not have this allele (figure 4c). In comparison with cal-
culated accurate masses, mass error for detected T45S 
variant was 0.0056 Da. These results indicate the meth-
od has good potential for rapid detection of the ApoC1 
T45S variant. 
 
Figure 5. Antibody cartridge analysis of human plasma 
hemoglobin (Hb). (a) full MS spectrum shows the Hb 𝛼𝛼-/β-
chain ions with charge state from +11 to +20. SIM spectra 
(m/z scan window 1.2 Da) show the relative intensities of 
non-glycated (b) and glycated (c) Hb.   
Glycated hemoglobin is a stable minor Hb variant 
formed in vivo by the non-enzymatic, covalent attach-
ment of glucose. Relative quantitation of a particular Hb 
fraction, HbA1c, has been used as a marker of glycemia 
control in diabetes for decades.18 As shown in Figure 5, 
several hemoglobin species were identified using the 
protein detection cartridge, such as nonglycated 𝛼𝛼-/β-
chains (Figure 5a), and glycated 𝛼𝛼-/β-chains (Figure 5a 
insert spectrum). The Hb and glycated Hb were moni-
tored using single ion monitoring (SIM) of the +15 
charge state as shown in figure 5b and 5c. The mass er-
ror for the detected non-glycated Hb β-chain and gly-
cated Hb β-chain were 0.012 Da and -0.079 Da, respec-
tively. The relative intensity of glycated Hb was ~7% 
compared to unglycated Hb, which is similar to the ex-
pected proportion.19-20 The results indicate the method 
has potential for relative quantitation of Hb and HbA1c.  
Transthyretin (TTR) is a 55kDa homotetramer protein 
that transports thyroxine and retinol in blood and cere-
brospinal fluid. Misfolding and aggregation of wild-type 
(wt) and mutant transthyretin protein (TTR) is the cause 
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of transthyretin amyloidosis (ATTR), a severe and fatal 
disease characterized by abnormal deposits of TTR amy-
loids. Mass spectrometry is used to screen for ATTR.20 
The antibody cartridge was successfully used to detect 
wt TTR as well as various TTR mutants from human 
plasma samples. Supplementary Figure S4 shows the 
mass spectrum obtained for the +10 charge state of wt 
TTR.  The unmodified TTR was a relatively minor com-
ponent; the cysteine, glutathione, and sulfonate PTMs 
were all more intense. To reduce the complexity of the 
mass spectrum, we spiked the reducing agent Tris(2-
carboxyethyl)phosphine hydrochloride (TCEP-HCl). 
This procedure, performed on-cartridge in the extrac-
tion/spray solvent without a separate step, succeeding in 
eliminating the S-cysteine and S-glutathione modifica-
tions (Figure S4), although the S-sulfonation remained. 
Four different TTR mutants in six ATTR clinical sam-
ples were clearly identified and differentiated from wt 
TTR. Figure 6 shows the charge-state deconvoluted 
mass spectra obtained from a wt sample and a repre-
sentative ATTR sample.  The spectrum from the ATTR 
sample indicates the patient is heterozygous for wild 
type TTR and a TTR variant with a ∆m of 32.06 Da. 
This mass shift is consistent with substitution of valine-
30 for methionine, the most common mutation found in 
TTR associated neuropathy.22  
 
Figure 6. The charge-state deconvoluted MS spectra ob-
tained by antibody cartridge analysis of human plasma 
from a wt sample (a) and a ATTR plasma sample (b). Only 
wild type TTR, including free thiol wt-TTR and S-
sulfonation wt-TTR, can be detected from normal sample, 
while a mutant TTR with ∆m=32.0 Da was identified from 
the ATTR sample. 
In summary, we describe a simple, all-in-one 3D 
printed cartridge which enables targeted protein detec-
tion from plasma samples by mass spectrometry.  The 
unique feature of this device is that both protein enrich-
ment as well as ionization occur from one device.  Be-
cause of the simplicity of the analytical procedure, this 
cartridge better enables MS-based detection of protein 
targets, which is important in clinical diagnostics and 
other fields.  While MS is expensive relative to tradi-
tional immunoassay detection methods, mass spectrome-
try is better suited for distinguishing post-translational 
modifications, sequence variants, and other proteoforms. 
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S1. Chemicals and materials  
Three human plasma samples were tested, including individual donated plasma, pooled human plasma, and de-
identified plasma samples from patients with transthyretin amyloidosis (ATTR samples). Anti-hemoglobin 
polyclonal antibody was purchased from Thermo Fisher Scientific (Rockford, IL, USA). Anti-transthyretin 
polyclonal antibody was purchased from LifeSpan BioSciences, Inc. (Seattle, WA, USA). Carboxyl latex 
beads (1.4 μm) was purchased from Molecular Probes, Inc. (Eugene, OR, USA). 1-(3-Dimethylaminopropyl)-
3-ethylcarbodiimide hydrochloride (EDAC hydrochloride) was purchased from Acros Organics (Fair Lawn, 
NJ, USA). Methanol and acetic acid was purchased from Fisher Scientific Co. (Fair Lawn, NJ, USA). 
Millipore glass-fiber membrane filters, single-walled carbon nanotubes (0.7-1.3 nm), and all other proteins and 
chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA). Amicon Ultra 0.5 mL centrifugal filter 
was purchased from Merck Millipore Ltd. (Tullagreen, Cork, Ireland). The antibody cartridge was 3D printed 
using a Stratasys Objet 30 pro using VeroBlue photopolymer (Eden Prairie, MN, U.S.A).  The antibody 
column was cut out of Delrin plastic tube (McMaster-Carr) (Elmuhurst, IL, U.S.A.). Porous polyethylene was 
purchased from Interstate Specialty Products (Sutton, MA, USA). 
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S2. Preparation of spray substrates 
Pretreatment of carbon nanotubes. The single-walled carbon nanotube powder was washed by immersion in 
methanol: water 1:1(v: v) and sonication for 15 minutes (3X), and followed by immersion in pure methanol 
and sonication for 15 minutes (3X), and then store in pure methanol as a slurry with a concentration about 10 
mg/mL. 
Preparation of porous polyethylene (PE). The PE was cut into rectangles (2.0cm X 0.5cm) and then washed 
by immersion in pure methanol and vortexing for 1 minute (3X) and followed by immersion in 1:1 methanol: 
water and vortexing for a minute (3X). Washed PE was than allow to dry before applying CNT. 
Preparation of CNT-dispersed spray substrates. The spray substrates, chromatography paper and porous 
polyethylene, were immersed in the CNT slurry and sonicated for 30 min. CNT-dispersed spray substrates 
were allow to dry and cut into pentagon shape with a sharp tip, as shown in Figure S1. 
Preparation of CNT-coated spray substrates. The paper substrate and washed thin piece of PE were placed 
on an absorbent pad, and the CNT slurry (10 mg/mL in methanol) was pipetted onto the upper surface of spray 
substrates. After the solvent pass though the spray substrate to the absorbent pad, most of the CNT stay on the 
surface of spray substrates. CNT-coated paper substrate was ready to use after drying and cut into pentagon 
shape with a sharp tip. CNT-coated PE need more treatment after drying, as follows: the upper surface was 
polished with a Kim wipe to remove the excess CNT and form a thin CNT-coated layer on the PE substrate, 
and then washed again as described in the preparation of porous polyethylene. The CNT coated PE substrate 
was allowed to dry, then cut into spray tips. To form the spray tip, one side of the rectangle (short side) was cut 
evenly to a fine triangular point. The CNT-PE tips could be re-used after washing. 
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S3. Photograph and SEM image of spray substrates 
 
 
Figure S1. Photograph and SEM image of different spray substrates. Spray substrate from left to right: untreated chromatography 
paper, CTN-dispersed chromatography paper, CNT-coated chromatography paper, CTN-dispersed porous polyethylene, and 
CTN-coated porous polyethylene.  
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S4. Full MS spectra of two proteins obtained using paper spray and CNT-coated PE substrate 
 
 
Figure S2. Full MS spectra obtained by ionizing 10 μg/mL myoglobin and 0.1 μg/mL lysozyme using paper spray (a, c) and the 
CNT-coated PE substrate (b, d). 
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S5. Detection limits of standard protein solution obtained by different spray substrates 
Table S1 lists the detection limits of three standard protein solution obtained by using the five different spray 
substrates shown in Figure S1. Detection limits were determined experimentally by analysis of serial dilutions 
of protein standards (S/N >3). 
 
Table S1. Limits of detection of proteins obtained by paper and 
PE spray substrates. 
Spray substrates 
Detection limits (μg/mL) 
Cytochrome c Myoglobin Lysozyme 
Paper 
Untreated 3 5 100 
CNT-dispersed 1 0.8 10 
CNT-coated 0.5 1 100 
PE 
CNT-dispersed 0.05 0.2 0.3 
CNT-coated 0.01 0.1 0.1 
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S6. Preparation of antibody coated membrane 
To prepare the antibody coated membrane, the antibodies were coated onto carboxyl latex beads first, the 
protocol for prepare antibody coated membrane (4 pieces) was as follows. All antibody and buffer was warmed 
to room temperature prior to use. 
    Carboxyl latex preparation: 
1. Pipette 50 μL (40 mg/mL, 1.4 μm diameter) latex microspheres and diluted with 150 μL MES buffer. 
2. Centrifuge the mixture to sediment the particles: 3000 rpm for 5 min. 
3. Remove supernatant and re-disperse the pellet in 150 μL MES buffer. 
4. Centrifuge again and remove the supernatant from the particles. 
5. Re-suspend pellet in 100 μL MES buffer by vortexing to ensure a completely suspend of the 
microsphere particles. 
Preparation of antibody-labeled latex beads: 
1. Add 10 mg EDAC powder into the latex suspension prepared above, and react for 15 min with 
constant vortex to activate the latex beads. 
2. Centrifuge the mixture to sediment the activated latex beads: 3000 rpm for 5 min. 
3. Remove supernatant and re-disperse the pellet in 100 μL MES buffer. 
4. Centrifuge again and remove the supernatant from the particles.  
5. Repeat step 3-4 twice more for a total of 3 washes. 
6. Re-suspend activated latex beads in 50 μL MES buffer by vortexing to ensure a completely. 
7. Add antibody solution (1 mg/mL, 250 μL, 10x excess) to the latex suspension prepared above. For the 
antibody solutions that contain sodium azide, they were treated by centrifuge filters to remove the 
azide prior to binding the antibody to latex beads. 
8. Incubate latex/antibody mixture with gentle mixing at room temperature for 5 hours. 
9. Centrifuge to separate the antibody-labeled latex beads from unbound antibody solution. 
10. Remove ad retain supernatant for the preparation of more antibody-labeled latex beads. 
11. Re-suspend the beads in 100 μL PBS buffer. 
12. Centrifuge again to sediment the beads. 
13. Repeat steps 11-12 twice more for a total of 3 washes. 
14. Re-suspend the final latex beads in 100 μL PBS buffer with 0.1% glycine. Store at 4℃ until use. 
Coat the antibody-labeled latex beads onto the glass-fiber membrane: Several 3-mm diameter glass-
fiber filter membranes (1.2 μm retention) were placed on an absorbent pad. Pipette re-suspend final latex bead 
prepared above onto the membranes, 25 μL for each membrane. Antibody coated membranes were allow to 
dry and placed at the bottom of the antibody column.  
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S7. Sample preparation 
Standard proteins were first dissolved in water at a concentration 1 mg/ml and then diluted with spray solvent 
(methanol/water 50:50 v: v, with 2% acetic acid) to the desired concentration. Experiments were performed on 
the same day that the protein samples were prepared. Human plasma was separated from donor human blood 
from K2EDTA treated vials, and stored at -4°C. ATTR samples were stored at -20°C and brought to room 
temperature prior to use. All plasma samples were diluted 1:10 with PBS buffer. Purchased antibodies were 
purified using the centrifugal filter to remove the azide from the store buffer. All plasma and buffer was 
warmed to room temperature prior to use. 
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S8. Experimental methods 
Direct Spray Ionization Using Paper and PE Substrate. Detection limits of standard protein samples were 
obtained by direct spray ionization from paper of PE substrate. The size of the pentangle shaped substrate was 
∼5 mm × 8 mm (base × height). Standard protein samples were diluted with 50:50 (v:v) methanol−water with 
2% acetic acid to different concentrations. 20 μL sample was deposited to the rear of the substrate and wicked 
through the substrate to the tip by capillarity. The paper or PE substrate, which was cut to a sharp point, was 
positioned 5 mm away from the atmospheric pressure inlet of the mass spectrometer and a high voltage of 5 
kV was then applied to the spray substrate, inducing an electrospray at the tip of the substrate. The solvent 
evaporates from the charged droplets generated by the electrospray process, leaving gas phase ions of the 
analyte molecules, which can then be detected by a mass spectrometer. 
Ionization Using Antibody Cartridge. As shown in the TOC figure, the diluted human plasma samples (1:10 
dilution, 20 μL plasma diluted with 180 μL deionized water) were added to the antibody column. The sample 
wicked through the antibody column and subsequently onto the absorbent pad contained within the bottom part 
of the cartridge. As the sample passed through the antibody column (within 5 min), the target proteins were 
retained on the antibody column while the excess matrix was absorbed onto the waste pad. The sample was 
then washed by applying 400 µL of deionized water to the antibody column; the deionized water also wicked 
through the column onto the absorbent pad. The target proteins were recovered from the antibody column and 
analyzed by sliding the column holder (as well as the antibody column) over and pushing the antibody column 
down so that the antibody column was in contact with the pentagon-shaped CNT-PE substrate rather than the 
waste pad. The cartridge was placed in front of the inlet to the mass spectrometer, and the extraction/spray 
solvent (typically 1:1 methanol:water with 2% acetic acid) was added to the top of the enrichment column. The 
solvent wicked through the antibody column, recovering the proteins in the process, and onto the spray 
substrate passively. For the detection of plasma TTR, 25 mM TECP-HCl was added to the spray solvent to 
perform the online reduction of the TTR posttranslational modifications. The reduction reaction was allowed to 
proceed on-cartridge for 5 minutes prior to ionization.  Ionization was induced directly from the paper 
substrate by applying a high voltage (5 kV typically) to the CNT-PE tip through a wire inserted from the side 
of the cartridge. 
Mass Spectrometry, Data Collection, and Data Processing. All the experiments were carried out with a Q 
Exactive Focus mass spectrometer (Thermo Fisher Scientific, San Jose, CA, USA). The instrument parameters 
were as follows: Positive ion mode in all experiments; Spray voltage typically 5 kV, spray voltage may vary in 
different cases to make the spray current at ~0.2 μA; Resolution 70,000; AGC target 1e6; Maximum inject 
time 100 ms; Capillary temperature 320°C; S-lens RF level 60.0; In the detection of apolipoprotein, 
hemoglobin, and transthyretin from diluted human plasma sample, in-source CID was set at 25.0 eV, 
Microscans set at 1 for full MS scan and set at 5 for SIM scan, SIM scan window 7.0 Da for apolipoprotein 
and 1.2 Da for hemoglobin. The software MagTran was used to generate the deconvoluted MS spectra of 
human plasma transthyretin. 
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S9. Taylor cone formed from CNT-coated paper 
 
Figure S3. Pictures of three different substrates before (left) and after (right) application of high voltage.  The CNT-PE (top row) 
and Paper (bottom row) are reproduced from the main text for comparison to CNT-coated paper (middle row).  
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S10. Reduction of TTR posttranslational modifications 
The reduction of TTR posttranslational modifications was performed during the protein extraction step. The 
TCEP-HCl was spiked into the spray solvent (methanol: water 1:1 v: v, with 2% acetic acid) at a concentration 
25 mM. As shown in Figure S3, some high relative abundance posttranslational modifications, such as S-
Cysteine and S-Glutathione were diminished after the TCEP-HCl reduction. The relative signal intensity of 
free thiol wild-type TTR increased significantly. However, the posttranslational modifications S-Sulfonation 
still exist in the spectrum. Increase the concentration of TCEP-HCl (from 25 mM to 50 mM) or reduction time 
(from 5 min to 20 min) can not remove the S-Sulfonation TTR from the sample. The reduction time was then 
optimized at 5 min with 25 mM TCEP-HCl in spray solvent. The reduction greatly simplifies the data analysis 
and quantification of human plasma TTR, as well as the mutant. 
 
 
Figure S4. TCEP-HCl reduction significantly reduces the posttranslational modifications of plasma TTR and enhances the MS 
response of free thiol wild-type TTR. 
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S11. Protein retention by the spray substrates 
An 80 µL aliquot of a 3 µg/mL of cytochrome C from equine heart was dissolved in the spray solvent and 
passed through either the paper spray substrate or the CNT-PE spray substrate in a manner consistent with the 
typical analysis.  A 50 µL aliquot was recovered from each spray substrate, and it was spiked with 0.5 µg of an 
internal standard protein (cytochrome c from Saccharomyces cerevisiae). The recovery of two substrates can 
be compared using the following formula:  
𝑹𝑹𝑪𝑪𝑪𝑪𝑪𝑪−𝑷𝑷𝑷𝑷
𝑹𝑹𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑
= 𝑨𝑨𝑨𝑨𝑪𝑪𝑨𝑨,𝑪𝑪𝑪𝑪𝑪𝑪−𝑷𝑷𝑷𝑷
𝑨𝑨𝑨𝑨𝑪𝑪𝑨𝑨,𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑 𝑨𝑨𝑨𝑨𝑪𝑪𝑳𝑳,𝑪𝑪𝑪𝑪𝑪𝑪−𝑷𝑷𝑷𝑷𝑨𝑨𝑨𝑨𝑪𝑪𝑳𝑳,𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑�     (1) 
Where 𝑹𝑹𝑪𝑪𝑪𝑪𝑪𝑪−𝑷𝑷𝑷𝑷
𝑹𝑹𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑
 is the relative recovery between the two substrates and AUCA and AUCL are the areas under the 
curve for the analyte and internal standard, respectively.  See Vega et al, Journal of the American Society of 
Mass Spectrometry 27(4), 726-734 (2016) for a full description of the data analysis. 
In the case of cytochrome C, 𝑹𝑹𝑪𝑪𝑪𝑪𝑪𝑪−𝑷𝑷𝑷𝑷
𝑹𝑹𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑𝒑
 was 1.8 ± 0.2 (N = 5), indicating that the protein recovered from the 
CNT-PE substrate was approximately double during the amount recovered from the paper substrate. This 
indicates that paper retained more target protein than CNT-PE.  Because the limit of detection for cytochrome 
C was about 300X lower for the CNT-PE substrate compared to the paper, the lower retention by the CNT-PE 
is apparently a relatively minor contributor compared to the improvement in ionization efficiency. 
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S12. Recovery of captured protein 
To determine the elution efficiency from of the captured protein from the antibody column, antibody coated 
latex beads were incubated offline with 1.2 mL of a 10 µg/mL cytochrome c (equine heart) aqueous solution. 
The beads were then washed 3 times and divided into six equal aliquots. Three of them were coated to the 
membrane disc identically to the typical analysis. The other three were extracted offline using methanol: water 
1:1 (v: v) with 2% acetic acid for 10 minutes while vortexing.   For both samples, an internal standard 
(cytochrome C from Saccharomyces cerevisiae, 0.6 µg) was spiked into the elution/spray solvent. 
The direct elution method used for the cartridge analysis was compared to offline recovery using equation 1 
above.   𝑹𝑹𝒅𝒅𝒅𝒅𝒑𝒑𝒑𝒑𝒅𝒅𝒅𝒅
𝑹𝑹𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒅𝒅𝒐𝒐𝒑𝒑
 was found to be 0.94 (N=3), indicating that extended offline extraction did not 
elute anymore protein than the direct elution method used in the protein cartridge. 
In a second experiment, the latex bead coated membranes were removed from the cartridge after 
analysis and subjected to offline extraction as described above.  No protein was detectable in the 
offline extraction.  This indicates that virtually all of the protein was eluted from the beads 
during the direct elution. 
